Sbi Securities Co., Ltd. Macrogenics Inc Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Macrogenics Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 3,043 shares of MGNX stock, worth $4,929. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,043
Previous 3,031
0.4%
Holding current value
$4,929
Previous $9.85 Million
60.77%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MGNX
# of Institutions
128Shares Held
53.5MCall Options Held
45.1KPut Options Held
143K-
Bellevue Group Ag Kuesnacht, V89.93MShares$16.1 Million0.29% of portfolio
-
Armistice Capital, LLC New York, NY6.3MShares$10.2 Million0.12% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$8.75 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$7.17 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$5.27 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $99.6M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...